Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Hope for schizophrenia sufferers?

This article was originally published in Clinica

Executive Summary

When a patient presents with signs of mental problems, a physician will normally reach for a questionnaire or a copy of official mental health classifications from the World Health Organization or American Psychiatric Association. By the time the physician has asked a few questions, the patient will be some way towards a diagnosis. If the doctor suspects schizophrenia, the next step is usually an appointment with a psychiatrist, and it may then take six months of diagnostic work-up to confirm schizophrenia and prescribe the right sort of anti-psychotic drugs or another treatment, such as electro-convulsive therapy.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT095276

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel